Skip to search formSkip to main contentSkip to account menu

NRAS NP_002515.1:p.G13X

Known as: NP_002515.1 :p.Gly13Xxx, GTPase NRas G13X, NRAS p.Gly13Xxx 
A change in the amino acid residue at position 13 in the GTPase NRas protein where glycine has been replaced by another amino acid.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Strong Regulation of Medical Products:
• Effective regulation and governance of the pharmaceutical sector is key to effective delivery of healthcare. In the Greater… 
2018
2018
NRAS mutace u pacientů s akutní myeloidní leukémií
Diplomova prace se věnuje studiu mutaci v genu NRas u pacientů s de novo akutni myeloidni leukemii (AML). Mutace v genu NRas jsou… 
2017
2017
Best of ASTRO 2016 Czech Republic 20
1: (9755) The Initial Results for a Phase 3 Study of Short-term Versus Long-term Chemoradiation Therapy in Locally Advanced… 
2017
2017
MUTACIJA GENA KRAS I NRAS U DESNOSTRANOM I LIJEVOSTRANOM KARCINOMU DEBELOG CRIJEVA PACIJENATA LIJEČENIH U KBC-u SPLIT OD 2014. DO 2017. GODINE
Cilj istraživanja: karcinom debelog crijeva jedan je od najcescih tumora na kojeg otpada 9,7% svih zlocudnih bolesti. Cilj ovog… 
2016
2016
Untersuchungen zur Regulation und Bedeutung der Serinprotease HTRA1 in Tumorzellen
Die HtrA-Proteine (high temperature requirement A) gehoren zu einer Familie von hochkonservierten Serin-Proteasen, die sowohl… 
2016
2016
I68 NRAS ‘Apne Jung’ (Our Fight Against RA) Engaging with South Asian RA Population
2014
2014
Rôle des protéines RAF dans le développement du mélanome induit par NRas q61k chez la souris
La voie de signalisation Ras/Raf/MEK/ERK joue un role crucial dans le melanome, avec des mutations sur le: genes BRaf et NRas… 
2003
2003
NRAS hypermutability in familial melanoma with CDKN2A mutations--cause and effect?
The frequency of cutaneous melanoma has been increasing worldwide for several decades. Approximately 8%–12% of melanomas occur in…